Fortis malar hospitals Limited has submitted its quarterly compliance certificate under SEBI regulations for the quarter ended March 31, 2026. The healthcare company filed the mandatory certificate with BSE Limited on April 8, 2026, ensuring adherence to regulatory requirements for depositories and participants.

Regulatory Compliance Filing

The certificate was submitted pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018. Company Secretary and Compliance Officer Vinti Verma signed and filed the document with BSE Limited's Department of Corporate Services on April 8, 2026.

Registrar and Transfer Agent Certificates

KFin Technologies Limited, formerly known as KFin Technologies Private Limited, serves as the company's Registrar and Transfer Agent. The firm issued certificates to both major depositories on April 1, 2026, confirming compliance with regulatory requirements.

Depository Confirmations

Rajitha Cholleti, Vice President at KFin Technologies Limited, signed certificates addressed to:

• Central Depository Services (India) Limited (CDSL) - Marathon Futurex, Lower Parel, Mumbai
• National Securities Depository Limited (NSDL) - Trade World, Lower Parel, Mumbai

Both certificates confirm that details of securities dematerialized and rematerialized during the quarter ended March 31, 2026, have been furnished to all stock exchanges where Fortis Malar Hospitals Limited shares are listed.

Company Information

Fortis Malar Hospitals Limited operates with its registered office located at Fortis Hospital, Sector 62, Phase VIII, Mohali. The company maintains its corporate identification number as L85110PB1989PLC045948 and conducts business under the healthcare sector.

The quarterly filing represents standard regulatory compliance for listed companies, ensuring transparency in securities transactions and maintaining investor confidence through proper documentation and reporting procedures.

Fortis Malar Hospitals Limited has successfully resolved an income tax demand through the processing of its rectification application, marking a favorable outcome for the healthcare company. The development was communicated to BSE Limited on March 28, 2026, in compliance with regulatory disclosure requirements.

Tax Demand Resolution Details

The Centralized Processing Centre (CPC) of the Income Tax department in Bengaluru processed the company's rectification application filed under Section 154 of the Income Tax Act, 1961. The application was filed against an intimation order issued under Section 143(1) of the Income Tax Act for Assessment Year 2024-25.

Favorable Outcome

The rectification order has resulted in a complete deletion of the original demand of INR 20.82 lakhs that was raised in the Section 143(1) intimation. Additionally, the order has determined a refund of Rs.41.11 lakhs in favor of the company, representing a significant positive development.

Financial Impact Assessment

The company has disclosed that there are no expected financial implications due to compensation, penalty, or other charges arising from this matter. The quantum of claims has been reported as nil, indicating a clean resolution of the tax dispute.

Regulatory Compliance

The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, in continuation of the company's earlier communication dated December 24, 2025. The announcement follows the prescribed format under Schedule III of the Listing Regulations and SEBI Master Circular guidelines.

This resolution demonstrates the company's proactive approach to tax compliance and its ability to successfully navigate regulatory processes. The favorable outcome, including the deletion of the original demand and determination of a refund, strengthens the company's financial position.